Page last updated: 2024-08-26

1,4-dihydropyridine and Sclerosis, Systemic

1,4-dihydropyridine has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allanore, Y; Borderie, D; Ekindjian, OG; Kahan, A; Lemaréchal, H	1

Trials

1 trial(s) available for 1,4-dihydropyridine and Sclerosis, Systemic

Article	Year
Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis. The American journal of medicine, 2004, May-01, Volume: 116, Issue:9 Topics: Adult; Aged; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Scleroderma, Systemic; Sulfhydryl Compounds; Time Factors	2004

Article

Year

Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis.

The American journal of medicine, 2004, May-01, Volume: 116, Issue:9

Topics: Adult; Aged; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Scleroderma, Systemic; Sulfhydryl Compounds; Time Factors

2004